Lactobacillus acidophilus LB: a useful pharmabiotic for the treatment of digestive disorders
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Dysbiosis, a loss of balance between resident bacterial communities and their host, is associated with multiple diseases, including inflammatory bowel diseases (nonspecific chronic ulcerative colitis and Crohn’s disease), and digestive functional disorders. Probiotics, prebiotics, synbiotic organisms and, more recently, pharmabiotics, have been shown to modulate the human microbiota. In this review, we provide an overview of the key concepts relating to probiotics, prebiotics, synbiotic organisms, and pharmabiotics, with a focus on available clinical evidence regarding the specific use of a unique pharmabiotic, the strain Lactobacillus acidophilus LB ( Lactobacillus boucardii), for the management of gastrointestinal disorders. Since it does not contain living organisms, the administration of L. acidophilus LB is effective and safe as an adjuvant in the treatment of acute diarrhea, chronic diarrhea, and antibiotic-associated diarrhea, even in the presence of immunosuppression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634
Effects of probiotics, prebiotics, and synbiotics on human health
Markowiak, P., & Śliżewska, K. (2017) · Nutrients · doi:10.3390/nu9091021 · Cited by 2,401 · cited 1×
“difficile; (5) avoiding adverse events from the eradication of Helicobacter pylori; (6) irritable bowel syndrome; (7) chronic constipation in adults; (8) lactose intolerance; (9) concomitant use with standard therapy for the induction or maintenance of remission in mild or moderate chronic non-specific ulcerative coli…”
BackgroundRole of the gut microbiota in nutrition and health
Valdes, A. M., Walter, J., Segal, E., & Spector, T. D. (2018) · BMJ · doi:10.1136/bmj.k2179 · Cited by 2,375
Ursell, L. K., Metcalf, J. L., Parfrey, L. W., & Knight, R. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00493.x · Cited by 1,255
Probiotics, gut microbiota, and their influence on host health and disease
Sánchez, B., Delgado, S., Blanco‐Míguez, A., Lourenço, A., Gueimonde, M., & Margolles, A. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600240 · Cited by 1,104
Dunne, C., O’Mahony, L., Murphy, L., Thornton, G., Morrissey, D., O’Halloran, S., Feeney, M., Flynn, S., Fitzgerald, G., Daly, C., et al. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.386s · Cited by 922
Mechanisms and consequences of intestinal dysbiosis
Weiss, G. A., & Hennet, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2509-x · Cited by 775
Su, G. L., Ko, C. W., Bercik, P., Falck-Ytter, Y., Sultan, S., Weizman, A. V., & Morgan, R. L. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.059 · Cited by 421
Lactobacillus species: Taxonomic complexity and controversial susceptibilities
Goldstein, E. J. C., Tyrrell, K. L., & Citron, D. M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ072 · Cited by 392
Choosing an appropriate probiotic product for your patient: An evidence-based practical guide
Sniffen, J. C., McFarland, L. V., Evans, C. T., & Goldstein, E. J. C. (2018) · PLOS ONE · doi:10.1371/journal.pone.0209205 · Cited by 265
Cited by
Lactobacillus Bacteremia and Probiotics: A Review
Kullar, R., Goldstein, E. J. C., Johnson, S., & McFarland, L. V. (2023) · Microorganisms · doi:10.3390/microorganisms11040896 · Cited by 156
“Further, since most Lactobacillus species are probiotic microorganisms, they produce enzymes that display antibiotic, anticancer, and immunosuppressant properties [4].”
BackgroundRevisiting the intestinal microbiome and its role in Diarrhea and constipation
Iancu, M. A., Profir, M., Roşu, O. A., Ionescu, R. F., Cretoiu, S. M., & Gaspar, B. S. (2023) · Microorganisms · doi:10.3390/microorganisms11092177 · Cited by 53
“Species of Lactobacillus , Bifidobacterium , Saccharomyces boulardii , Clostridium butyricum , and some species of Escherichia are some of the bacteria generally used as probiotics [117].”
Aleman, R. S., Avila, D., Avila, A., Losso, J. N., Picha, D., Xu, Z., & Aryana, K. (2023) · Fermentation · doi:10.3390/fermentation9080715 · Cited by 4
Metadata
- Authors
- María Remes-Troche, J., Coss-Adame, E., Ángel Valdovinos-Díaz, M., Gómez-Escudero, O., Eugenia Icaza-Chávez, M., Antonio Chávez-Barrera, J., Zárate-Mondragón, F., Antonio Velarde-Ruíz Velasco, J., Rafael Aceves-Tavares, G., Antonio Lira-Pedrín, M., Cerda-Contreras, E., Carmona-Sánchez, R. I., Guerra López, H., & Solana Ortiz, R.
- Venue
- Therapeutic Advances in Gastroenterology
- Publisher
- SAGE Publications
- Published
- 2020-01
- Volume
- 13
- Pages
- 1756284820971201-1756284820971201
- ISSN
- 1756-283X (ISSN-L)
- 1756-2848
- OpenAlex
- W3106586717
- Cited by
- 77
- References
- 10
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lactobacillus acidophilus LB: a useful pharmabiotic for the treatment of digestive disorders. https://app.cochat.ai/papers/10.1177/1756284820971201
- The paper
- María Remes-Troche, J., Coss-Adame, E., Ángel Valdovinos-Díaz, M., Gómez-Escudero, O., Eugenia Icaza-Chávez, M., Antonio Chávez-Barrera, J., Zárate-Mondragón, F., Antonio Velarde-Ruíz Velasco, J., Rafael Aceves-Tavares, G., Antonio Lira-Pedrín, M., Cerda-Contreras, E., Carmona-Sánchez, R. I., Guerra López, H., & Solana Ortiz, R. (2020). Lactobacillus acidophilus LB: a useful pharmabiotic for the treatment of digestive disorders. Therapeutic Advances in Gastroenterology. https://doi.org/10.1177/1756284820971201
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.